About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT00219557

AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

This is a Phase 2 study being conducted at multiple centers in the United States, Europe and Canada. Patients having pancreatic cancer that is locally advanced or that has spread to other parts of the...

Lead sponsor: Pfizer•17 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Pfizer

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•patients with advanced (localized but surgically unresectable or metastatic) histologically/cytologically proven epithelial cancer of the exocrine pancreas
•no prior therapy for metastatic disease

Exclusion Criteria

•patients with locally advanced disease who are candidates for radiation therapy.
•uncontrolled brain metastases (a controlled brain metastasis must be previously treated, asymptomatic, and without growth for 4 months)

Related studies

RECRUITINGPhase 1/2

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

NCT07542041 · Pancreatic Cancer, Pancreatic Neoplasms, and more

A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

NCT03937453 · Pancreatic Cancer, Pancreatic Neoplasms, and more

RECRUITINGPhase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT06885697 · Mesothelioma, Neoplasms, and more

RECRUITINGPhase 1/2

Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer

NCT04146298 · Pancreatic Cancer, Pancreatic Neoplasms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 14, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment111

Start dateJul 2005

Last updatedMay 14, 2019

Condition

Pancreatic Neoplasms

Locations shown

East Bay Medical Oncology/Hematology Medical Associates Inc.

Antioch, California

Alta Bates Comprehensive Cancer Center

Berkeley, California

Bay Area Cancer Research Group

Concord, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 14, 2019Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions